Breakthrough research shows B/F/TAF single-tablet regimen offers safe, effective HIV treatment for patients with end-stage renal disease on hemodialysis.
Exploring the hidden threat of occult hepatitis B infection in hemodialysis patients, its detection challenges, and modern clinical strategies.